The Research Review sets out how the UK will focus £390 million per year over the next 4 years on research and innovation to help address the great global challenges of the 21st century. It responds to the objectives set out in the UK Aid Strategy which deliver in the UK’s national interests. These include strengthening resilience and crisis response, promoting global prosperity, tackling extreme poverty and helping the world’s most vulnerable, while ensuring value for money for the taxpayer.
The UK’s scientific, research and technical expertise is one of our greatest strengths. As countries develop and leave aid dependency behind they will increasingly turn to the UK, not for financial resources, but for its intellectual leadership and scientific expertise.
UK aid is increasing investment in science and technology today to build a more secure and prosperous world for future generations. We will continue to invest around 3% of DFID’s budget on research. We will also invest an additional £357 million during the Spending Review period to fund research on infectious diseases through the Ross Fund Portfolio which has been established to develop, test and deliver a range of new products to help combat serious diseases in developing countries.